📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. (2017)

First Author: Ali HR

Attributed to: `Analysis of neo-antigens and immune profiles of Asian breast cancer patients, focusing on common germline deletion of APOBEC3B cytosine deaminase funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdx266

PubMed Identifier: 28525534

Publication URI: http://europepmc.org/abstract/MED/28525534

Type: Journal Article/Review

Volume: 28

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 8

ISSN: 0923-7534